The Hepatoprotective And Hypolipidemic Effects Of Spirulina ( Arthrospira Platensis) Supplementation In A Cretan Population With Non-alcoholic Fatty Liver Disease: A Prospective Pilot Study
Notes for this study:
||Mean and SD. HOMA-IR. Before 4.6 (2.1), after 3.7 (1.6).
|Number of Subjects
In a 6-month non-randomized, open-label pilot trial, 15 participants with NAFLD took 6 g/d of spirulina.
There was a reduction in AST, ALT, and γ-GT compared with baseline, though there weren't any sonographic improvements. There was an improvement in triglycerides, HDL, LDL, total cholesterol, insulin resistance, hemoglobin, atherogenic index, and body weight.